The E26 transformation-specific (ETS) transcription factor family is widely expressed and implicated in tumorigenesis.
Among them, ETV4 plays a crucial role in cancer progression.
However, its broader impact on prognosis and immune regulation across different malignancies remains insufficiently understood.
